BRPI0501120A - oral and parenteral pharmaceutical compositions containing high concentrations of aromatic solubilizing agents - Google Patents

oral and parenteral pharmaceutical compositions containing high concentrations of aromatic solubilizing agents

Info

Publication number
BRPI0501120A
BRPI0501120A BRPI0501120A BRPI0501120A BR PI0501120 A BRPI0501120 A BR PI0501120A BR PI0501120 A BRPI0501120 A BR PI0501120A BR PI0501120 A BRPI0501120 A BR PI0501120A
Authority
BR
Brazil
Prior art keywords
pharmaceutical compositions
compositions containing
solubilizing agents
high concentrations
oral
Prior art date
Application number
Other languages
Portuguese (pt)
Inventor
Henry Jun Suzuki
Original Assignee
Henry Jun Suzuki
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Henry Jun Suzuki filed Critical Henry Jun Suzuki
Priority to BRPI0501120 priority Critical patent/BRPI0501120A/en
Priority to ARP060100572A priority patent/AR053333A1/en
Priority to PCT/BR2006/000027 priority patent/WO2006086864A1/en
Publication of BRPI0501120A publication Critical patent/BRPI0501120A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

"COMPOSIçõES FARMACêUTICAS ORAIS E PARENTERAIS CONTENDO ALTAS CONCENTRAçõES DE AGENTES SOLUBILIZANTES AROMáTICOS". A presente invenção consiste de composições farmacêuticas contendo uma quantidade significativa de ingredientes ativos dissolvidos em fase oleosa, caracterizadas por conterem altas concentrações de agentes solubilizantes aromáticos, bem como processos de manufatura de tais composições. Mais especificamente, compreende composições farmacêuticas orais ou parenterais contendo uma quantidade significativa de ingredientes ativos dissolvidos em fase oleosa, caracterizadas por conterem agentes solubilizantes aromáticos numa quantidade superior a 10% em massa em relação aos demais excipientes presentes na fase oleosa."ORAL AND PARENTAL PHARMACEUTICAL COMPOSITIONS CONTAINING HIGH CONCENTRATIONS OF AROMATIC SOLUBILIZING AGENTS". The present invention consists of pharmaceutical compositions containing a significant amount of active ingredients dissolved in oil phase, characterized in that they contain high concentrations of aromatic solubilizing agents, as well as manufacturing processes of such compositions. More specifically, it comprises oral or parenteral pharmaceutical compositions containing a significant amount of active ingredients dissolved in an oil phase, characterized in that they contain aromatic solubilizing agents in an amount greater than 10% by weight relative to the other excipients present in the oil phase.

BRPI0501120 2005-02-18 2005-02-18 oral and parenteral pharmaceutical compositions containing high concentrations of aromatic solubilizing agents BRPI0501120A (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
BRPI0501120 BRPI0501120A (en) 2005-02-18 2005-02-18 oral and parenteral pharmaceutical compositions containing high concentrations of aromatic solubilizing agents
ARP060100572A AR053333A1 (en) 2005-02-18 2006-02-17 ORAL AND PARENTERAL PHARMACEUTICAL COMPOSITIONS CONTAINING HIGH CONCENTRATIONS OF AROMATIC SOLUBILIZING AGENTS
PCT/BR2006/000027 WO2006086864A1 (en) 2005-02-18 2006-02-20 Pharmaceutical compositions comprising aromatic solubilizing agents

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BRPI0501120 BRPI0501120A (en) 2005-02-18 2005-02-18 oral and parenteral pharmaceutical compositions containing high concentrations of aromatic solubilizing agents

Publications (1)

Publication Number Publication Date
BRPI0501120A true BRPI0501120A (en) 2006-10-03

Family

ID=36916128

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0501120 BRPI0501120A (en) 2005-02-18 2005-02-18 oral and parenteral pharmaceutical compositions containing high concentrations of aromatic solubilizing agents

Country Status (3)

Country Link
AR (1) AR053333A1 (en)
BR (1) BRPI0501120A (en)
WO (1) WO2006086864A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0500520A (en) * 2005-02-16 2006-09-26 Henry Jun Suzuki use of high melting aromatic flavoring agents as solubilizing agents or crystallization inhibitors in pharmaceutical compositions
US8173169B2 (en) 2007-07-11 2012-05-08 Hikma Pharmaceuticals Formulation and process for the preparation of modafinil
WO2024014959A2 (en) * 2022-07-15 2024-01-18 Seranovo Holding B.V. Micelle-generating formulations with improved hydrophobicity

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1132518A (en) * 1965-02-18 1968-11-06 Richardson Merrell Inc Medicinal composition
DE3339236A1 (en) * 1983-10-28 1985-05-09 Bayer Ag PREPARATION OF MEDICINAL PRODUCTS
CZ2003529A3 (en) * 2000-07-27 2003-09-17 Teva Pharmaceutical Industries Ltd. Crystalline and pure modafinil and process for preparing thereof
US6703398B2 (en) * 2001-11-26 2004-03-09 Oliver Yoa-Pu Hu Orally administered analgesic compositions containing nalbuphine

Also Published As

Publication number Publication date
AR053333A1 (en) 2007-05-02
WO2006086864A1 (en) 2006-08-24

Similar Documents

Publication Publication Date Title
EA201490489A1 (en) PURINUM DERIVATIVES AND THEIR APPLICATION AS A TALL-SIMILAR RECEPTOR MODULATORS 7
EA200900733A1 (en) SUBSTITUTED DERIVATIVES 2,3-DIHYDROIMIDAZO [1,2-c] HYNAZOLINE, USEFUL FOR THE TREATMENT OF HYPER-PROLIFERATIVE DISABILITIES AND DISEASES ASSOCIATED WITH ANGI-GENESIS
CY1115825T1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING LEVETIRAKETAM AND THEIR PREPARATION PROCEDURE
MX2010007523A (en) Novel pyrazolo [3, 4 -d] pyrimidine derivatives as anti -cancer agents.
NI200800299A (en) TRIAZOLOPYRAZINE COMPOUNDS USEFUL FOR THE TREATMENT OF DEGENERATIVE AND INFLAMMATORY DISEASES.
CR11554A (en) Pirrolo-Pirimidinas and Pirrolo-Piridinas
EA201291108A1 (en) PHARMACEUTICAL COMPOSITIONS IN THE FORM OF EMULSION WITH LOW CONTENT OF OIL, CONTAINING PROGESTOGEN
MA32442B1 (en) Inhibitors of syk protein kinase
PT1951730E (en) PYRIMIDINE DERIVATIVES LINED TO HETEROALKYL
MX2009003305A (en) Phlorizin analogs as inhibitors of sodium glucose co-transporter 2.
TN2009000180A1 (en) NOVEL 1,4-BENZOTHIEPIN-l,1-DIOXIDE DERIVATIVES WHICH ARE SUBSTITUTED WITH BENZYL GROUPS, METHOD FOR PRODUCING DRUGS CONTAINING SAID COMPOUNDS AND USE THEREOF
ATE417610T1 (en) COMPOSITION CONTAINING 6-Ä3-(1-ADAMANTYL)-4-METHOXYPHENYLÜ-2-NAPHTHANOIC ACID FOR THE TREATMENT OF DERMATOLOGICAL DISEASES
BR112012018384A2 (en) solid pharmaceutical composition with enhancers and methods of preparation thereof.
UY30220A1 (en) TETRAHYDROPIRIDOTIENOPIRIMIDINA COMPOUNDS AND METHODS FOR USE
ATE470443T1 (en) INDOL-1-YL ACID DERIVATIVES
MX357759B (en) Formulations and dosage forms of oxidized phospholipids.
BRPI0801239A2 (en) use of one or more benzopyranones, pharmaceutical composition and method for the prevention or treatment of monoamine oxidase-associated diseases, disorders and disorders
AR057148A1 (en) PHARMACOLOGICAL COMBINATIONS FOR THE TREATMENT OF RESPIRATORY ROAD DISEASES
EA200900582A1 (en) PHARMACEUTICAL COMPOSITIONS FOR PREVENTION AND TREATMENT OF EYE PATHOLOGIES
PL1965809T3 (en) Compositions for improving the health of the intestine and performance of animals, containing beta-glucans and alpha-fucans
BRPI0501120A (en) oral and parenteral pharmaceutical compositions containing high concentrations of aromatic solubilizing agents
NO20082848L (en) Pharmaceutical Formulation for the Treatment of Osteoarthritis Containing Clodronic Acid and Hyaluronic Acid
EA200900742A1 (en) AMINOCHINAZOLIN DERIVATIVES WITH DECREASING THROMBOCYTES PROPERTIES
AR074725A1 (en) MALEATE SALT OF 11- (2-PIRROLIDIN-1-IL-ETOXI) -14,19- DIOXA-5,7,26-TRIAZA-TETRACICLO (19.3.1.1 (2,6) .1 (8,12) HEPTACOSE -1 (25), 2 (26), 3,5,8,10,12 (27), 16,21,23-DECAENE
WO2006071564A3 (en) Aminium salts of 1,2,3-triazoles as prodrugs of drugs including antiviral agents

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal acc. article 33 of ipl - extension of time limit for request of examination expired